Evidence map›Paper›PMID 33262478›Full record

ArticleEye (London, England)2021

Risk factors for having diabetic retinopathy at first screening in persons with type 1 diabetes diagnosed under 18 years of age.

James Rafferty, David R Owens, Stephen D Luzio, Patrick Watts, Ashley Akbari, Rebecca L Thomas

Abstract read
In one paragraph

Article in Eye (London, England), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

James RaffertyDiabetes Research Unit Cymru, Swansea University Medical School, Singleton Park, Swansea, UK. j.m.rafferty@swansea.ac.uk.ORCID http://orcid.org/0000-0002-1667-7265
David R OwensDiabetes Research Unit Cymru, Swansea University Medical School, Singleton Park, Swansea, UK.
Stephen D LuzioDiabetes Research Unit Cymru, Swansea University Medical School, Singleton Park, Swansea, UK.
Patrick WattsDepartment of Ophthalmology, University Hospital of Wales, Cardiff, UK.
Ashley AkbariHealth Data Research UK, Swansea University Medical School, Singleton Park, Swansea, UK.ORCID http://orcid.org/0000-0003-0814-0801
Rebecca L ThomasDiabetes Research Unit Cymru, Swansea University Medical School, Singleton Park, Swansea, UK.

Funding

Wellcome Trust
6 · The paper itself

Abstract

objectiveTo determine the risk factors for having diabetic retinopathy (DR) in children and young people (CYP) with type 1 diabetes (T1DM) at first screening.

methodsRecords from the Diabetes Eye Screening Wales (DESW) service for people in Wales, UK, with T1DM diagnosed under age 18 years were combined with other electronic health record (EHR) data in the Secure Anonymised Information Linkage (SAIL) Databank. Data close to the screening date were collected, and risk factors derived from multivariate, multinomial logistic regression modelling.

resultsData from 4172 persons, with median (lower quartile, upper quartile) age 16.3 (13.0, 22.3) years and duration of diabetes 6.6 (2.3, 12.3) years were analysed. 62.6% (n = 2613) had no DR, 26.7% (n = 1112) background DR, and 10.7% (n = 447) had referable DR (RDR). No RDR was observed under 19 years of age. Factors associated with an increased risk of DR were diabetes duration, elevated HbA

conclusionsThis study found that 37.4% of the study cohort had DR at first screening, the risk being greater the longer the duration of diabetes or higher the HbA

Indexed as

Diabetes Mellitus, Type 1Diabetes Mellitus, Type 2Diabetic RetinopathyAdolescentChildHumansMass ScreeningPrevalenceRisk Factors

Identifiers

PMID33262478
PMCPMC8452782

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.